RAPS and National University of Singapore Launch Regulatory Affairs Graduate Certificate Program
RAPS and the National University of Singapore have announced the official launch of their joint Graduate Certificate in Medical Devices Regulatory Affairs program.
The Regulatory Affairs Professionals Society (RAPS) and the National University of Singapore (NUS) have announced the official launch of their joint Graduate Certificate in Medical Devices Regulatory Affairs (MDRA) program. The program is intended for Singapore-based regulatory professionals, and was developed in partnership with the government of Singapore to cultivate an industry-ready regulatory workforce.
“Singapore has become an important center for biomedical research and business today,” said RAPS Executive Director Sherry Keramidas, PhD, FASAE, CAE. “This program will be the first to offer instruction specifically designed to develop the medical device regulatory knowledge that is in high demand by the global companies located there.”
The MDRA program builds the foundational knowledge, critical thinking and application skills required of regulatory professionals. The curriculum will be delivered through a combination of online training, interactive seminars, peer interaction and case-based learning, and will cover regulations of ASEAN nations, China, the Asia-Pacific region, the US and Europe.
The program draws on the teaching and research excellence of NUS’ biomedical engineering faculty and the real world expertise of RAPS’ renowned regulatory leaders from around the world.
Enrollment is open from now until 8 August. Visit www.bioeng.nus.edu.sg/edu/mdra.html for full program details and application information, or contact the RAPS Pan-Asia office at [email protected] or Tel: +65 6496 5507.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
